The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized, multicenter, phase II trial of camrelizumab (Cam) with and without metastasis-directed therapy (MDT) in recurrent/metastatic nasopharyngeal carcinoma (R/M-NPC).
 
Xin Zhang
No Relationships to Disclose
 
Jin Yan
No Relationships to Disclose
 
Qianqian Lei
No Relationships to Disclose
 
Lu Zhang
No Relationships to Disclose
 
Jieying Yang
No Relationships to Disclose
 
Sze Huey Tan
No Relationships to Disclose
 
Melvin L.K. Chua
Leadership - Digital Life Line
Stock and Other Ownership Interests - BeiGene (I); Digital Life Line
Honoraria - Janssen Oncology; Varian Medical Systems
Consulting or Advisory Role - BeiGene; ImmunoSCAPE; IQVIA; Janssen Oncology; Merck Sharp & Dohme; PVmed; Telix Pharmaceuticals
Speakers' Bureau - AstraZeneca; Bayer; Janssen
Research Funding - BeiGene; Decipher Biosciences; EVYD Technology; MVision; PVmed
Patents, Royalties, Other Intellectual Property - High Sensitivity Lateral Flow Immunoassay For Detection of Analyte in Samples (10202107837T), Singapore. (Danny Jian Hang Tng, Chua Lee Kiang Melvin, Zhang Yong, Jenny Low, Ooi Eng Eong, Soo Khee Chee)
(OPTIONAL) Uncompensated Relationships - Alice's Arc
 
Ying Wang
No Relationships to Disclose
 
Jiangdong Sui
No Relationships to Disclose